{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:41:41Z","timestamp":1793306501056,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.diabres.2023.111016","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T04:32:28Z","timestamp":1700195548000},"page":"111016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM"],"prefix":"10.1016","volume":"206","author":[{"given":"Santo","family":"Colosimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip Kumar","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirthankar","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-9860","authenticated-orcid":false,"given":"Giulio","family":"Marchesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.111016_b0005","series-title":"Physical Activity and Type 2 Diabetes : Therapeutic Effects and Mechanisms of Action","first-page":"59","article-title":"Metabolic Inflexibility and Insulin Resistance in Skeletal Muscle","author":"Goodpaster","year":"2008"},{"key":"10.1016\/j.diabres.2023.111016_b0010","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J Clin Investi"},{"key":"10.1016\/j.diabres.2023.111016_b0015","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1128\/MCB.00797-10","article-title":"Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway","volume":"30","author":"Choi","year":"2010","journal-title":"Mo Cell Biol"},{"key":"10.1016\/j.diabres.2023.111016_b0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI114142","article-title":"Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance","volume":"84","author":"Groop","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2023.111016_b0025","first-page":"271","article-title":"Mechanisms of action of thiazolidinediones","volume":"27","author":"Girard","year":"2001","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0030","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/db11-0425","article-title":"Fatty acids, obesity, and insulin resistance: Time for a reevaluation","volume":"60","author":"Karpe","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/db10-0867","article-title":"Downregulation of adipose tissue fatty acid trafficking in obesity: A driver for ectopic fat deposition?","volume":"60","author":"McQuaid","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0040","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jhep.2022.08.010","article-title":"Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease","volume":"77","author":"Pafili","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2023.111016_b0045","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/db21-0160","article-title":"Subcutaneous adipose tissue metabolic function and insulin sensitivity in people with obesity","volume":"70","author":"Koh","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161148","article-title":"AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels","volume":"34","author":"Hardie","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.diabres.2023.111016_b0055","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Cant\u00f3","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2023.111016_b0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","article-title":"SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome","volume":"44","author":"Hirschey","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.diabres.2023.111016_b0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1469-7793.2001.00295.x","article-title":"The effects of increasing exercise intensity on muscle fuel utilisation in humans","volume":"536","author":"van Loon","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2337\/diacare.17.8.924","article-title":"Exercise in individuals with IDDM","volume":"17","author":"Wasserman","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.111016_b0075","first-page":"E380","article-title":"Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration","volume":"265","author":"Romijn","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/db09-0942","article-title":"Adipocyte turnover: relevance to human adipose tissue morphology","volume":"59","author":"Arner","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1043-2760(03)00143-7","article-title":"Fatty acid mobilization from adipose tissue during exercise","volume":"14","author":"Horowitz","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/db07-1438","article-title":"Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans","volume":"58","author":"Staiger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0095","doi-asserted-by":"crossref","first-page":"E882","DOI":"10.1152\/ajpendo.00769.2007","article-title":"Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited","volume":"294","author":"Dub\u00e9","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1172\/JCI114516","article-title":"Adrenergic regulation of lipolysis in situ at rest and during exercise","volume":"85","author":"Arner","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2023.111016_b0105","doi-asserted-by":"crossref","first-page":"E1144","DOI":"10.1152\/ajpendo.2000.278.6.E1144","article-title":"Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women","volume":"278","author":"Horowitz","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0110","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1152\/jappl.1999.87.4.1413","article-title":"Effect of training status on fuel selection during submaximal exercise with glucose ingestion","volume":"87","author":"van Loon","year":"1999","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0115","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1152\/jappl.1984.56.5.1217","article-title":"Effect of exercise training on whole-body insulin sensitivity and responsiveness","volume":"56","author":"James","year":"1984","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0120","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.2337\/db15-0809","article-title":"Exercise and Weight Loss Improve Muscle Mitochondrial Respiration, Lipid Partitioning, and Insulin Sensitivity After Gastric Bypass Surgery","volume":"64","author":"Coen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/meta.2002.31326","article-title":"Long- and medium-chain fatty acid oxidation is increased in exercise-trained human skeletal muscle","volume":"51","author":"Jong-Yeon","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2023.111016_b0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI78016","article-title":"Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity","volume":"125","author":"Coen","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2023.111016_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2013.06.018","article-title":"The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging","volume":"379","author":"Toledo","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.diabres.2023.111016_b0140","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1056\/NEJMoa033179","article-title":"Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease","volume":"350","author":"Klein","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2023.111016_b0145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2023.111016_b0150","doi-asserted-by":"crossref","first-page":"e0166263","DOI":"10.1371\/journal.pone.0166263","article-title":"Insulin clearance is associated with hepatic lipase activity and lipid and adiposity traits in mexican Americans","volume":"11","author":"Labadzhyan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2023.111016_b0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/dom.12272","article-title":"Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis","volume":"16","author":"Armstrong","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","article-title":"Surrogate markers of insulin resistance: A review","volume":"1","author":"Singh","year":"2010","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0165","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1042\/CS20170261","article-title":"Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes","volume":"131","author":"Brouwers","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2023.111016_b0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"Ortiz-Lopez","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.111016_b0175","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diabres.2023.111016_b0180","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00125-008-1116-7","article-title":"Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause","volume":"51","author":"Taylor","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.111016_b0185","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.111016_b0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.111016_b0195","doi-asserted-by":"crossref","unstructured":"Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes AC, Aribisala BS, et al. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for \u03b2 cell recovery. Cell Metab 2018;28:547-56.e3. 10.1016\/j.cmet.2018.07.003.","DOI":"10.1016\/j.cmet.2018.07.003"},{"key":"10.1016\/j.diabres.2023.111016_b0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","article-title":"Understanding the mechanisms of reversal of type 2 diabetes","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2023.111016_b0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: a reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0210","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.111016_b0215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2023.111016_b0220","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1042\/CS20170987","article-title":"Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?","volume":"131","author":"Gastaldelli","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2023.111016_b0225","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.2744","article-title":"Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration","volume":"18","author":"Sun","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2023.111016_b0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nm.4245","article-title":"Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion","volume":"23","author":"Hong","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2023.111016_b0235","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/10715762.2013.830717","article-title":"Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?","volume":"47","author":"Garc\u00eda-Ruiz","year":"2013","journal-title":"Free Radic Res"},{"key":"10.1016\/j.diabres.2023.111016_b0240","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2023.111016_b0245","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2023.111016_b0250","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.3390\/nu7115475","article-title":"The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis","volume":"7","author":"Saponaro","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.diabres.2023.111016_b0255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2017.74","article-title":"NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD","volume":"14","author":"Mann","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.111016_b0260","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2337\/db08-1078","article-title":"Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet\u2013induced insulin resistance","volume":"58","author":"Bruce","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0270","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.2337\/dcS13-2003","article-title":"In vivo actions of peroxisome proliferator-activated receptors: Glycemic control, insulin sensitivity, and insulin secretion","volume":"36","author":"Eldor","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.111016_b0275","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"Sahebkar","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.diabres.2023.111016_b0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/jm500695e","article-title":"Recent advances in the development of acetyl-CoA carboxylase (ACC) inhibitors for the treatment of metabolic disease","volume":"58","author":"Bourbeau","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.diabres.2023.111016_b0285","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/db13-0368","article-title":"AMPK: a target for drugs and natural products with effects on both diabetes and cancer","volume":"62","author":"Hardie","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc10-0665","article-title":"Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study","volume":"34","author":"Calori","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.111016_b0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.21983","article-title":"Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver","volume":"47","author":"Perseghin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2023.111016_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.711484","article-title":"Nonalcoholic fatty liver disease, liver fibrosis and cardiovascular disease in the adult US population","volume":"12","author":"Ciardullo","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2023.111016_b0310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.diabres.2023.111016_b0315","doi-asserted-by":"crossref","first-page":"H3270","DOI":"10.1152\/ajpheart.00887.2007","article-title":"Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy","volume":"293","author":"Neglia","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0320","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.2174\/1381612821666150710150445","article-title":"Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets","volume":"21","author":"Fukushima","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.diabres.2023.111016_b0325","first-page":"860","article-title":"Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction","volume":"33","author":"De Jong","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.diabres.2023.111016_b0330","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.diabres.2023.111016_b0335","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","article-title":"Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.diabres.2023.111016_b0340","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.111016_b0345","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2013an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2023.111016_b0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1015372407647","article-title":"Electron transport chain defects in heart failure","volume":"7","author":"Casademont","year":"2002","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.diabres.2023.111016_b0355","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cvr\/cvs424","article-title":"Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload","volume":"97","author":"Zhabyeyev","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2023.111016_b0360","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yjmcc.2007.11.006","article-title":"The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover","volume":"44","author":"O'Donnell","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.diabres.2023.111016_b0365","first-page":"H742","article-title":"Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts","volume":"267","author":"Allard","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0370","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacbts.2016.06.009","article-title":"Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: Implications for cardiac reloading and conditioning","volume":"1","author":"Diakos","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.diabres.2023.111016_b0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-3565(25)10243-7","article-title":"An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts","volume":"264","author":"Lopaschuk","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.diabres.2023.111016_b0380","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4","volume":"304","author":"Mori","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0385","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4613-0333-6_25","article-title":"Control of oxidative metabolism in volume-overloaded rat hearts: effect of pretreatment with propionyl-L-carnitine","volume":"388","author":"Moravec","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.diabres.2023.111016_b0390","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation\u2013a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.diabres.2023.111016_b0395","doi-asserted-by":"crossref","first-page":"e7533","DOI":"10.1371\/journal.pone.0007533","article-title":"Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling","volume":"4","author":"Funada","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2023.111016_b0400","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmcc.2002.2063","article-title":"Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways","volume":"34","author":"Hue","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.diabres.2023.111016_b0405","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvw051","article-title":"Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression","volume":"110","author":"Byrne","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2023.111016_b0410","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI7605","article-title":"Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart","volume":"104","author":"Abel","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2023.111016_b0415","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.0000045671.62860.98","article-title":"Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study","volume":"107","author":"Rutter","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.111016_b0420","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1113\/jphysiol.2004.061473","article-title":"Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates","volume":"558","author":"Niu","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.diabres.2023.111016_b0425","doi-asserted-by":"crossref","first-page":"25836","DOI":"10.1016\/S0021-9258(19)74465-2","article-title":"Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart","volume":"268","author":"Saddik","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2023.111016_b0430","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0026-0495(94)90241-0","article-title":"Total-body and myocardial substrate oxidation in congestive heart failure","volume":"43","author":"Paolisso","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2023.111016_b0435","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","article-title":"Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob\/ob mouse hearts","volume":"53","author":"Mazumder","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0440","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cardfail.2006.06.005","article-title":"Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction","volume":"12","author":"Tuunanen","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.diabres.2023.111016_b0445","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.111016_b0450","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s003800070022","article-title":"A nuclear complex containing PPARalpha\/RXRalpha is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic function","volume":"15","author":"Kanda","year":"2000","journal-title":"Heart Vessels"},{"key":"10.1016\/j.diabres.2023.111016_b0455","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.yjmcc.2008.03.021","article-title":"The PPAR trio: regulators of myocardial energy metabolism in health and disease","volume":"44","author":"Madrazo","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.diabres.2023.111016_b0460","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCGENETICS.113.000404","article-title":"Mechanical unloading promotes myocardial energy recovery in human heart failure","volume":"7","author":"Gupte","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.diabres.2023.111016_b0465","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCRESAHA.111.243964","article-title":"PGC-1\u03b2 deficiency accelerates the transition to heart failure in pressure overload hypertrophy","volume":"109","author":"Riehle","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2023.111016_b0470","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","article-title":"Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha","volume":"103","author":"Arany","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diabres.2023.111016_b0475","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0735-1097(96)00214-8","article-title":"Blood ketone bodies in congestive heart failure","volume":"28","author":"Lommi","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2023.111016_b0480","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/CIRCULATIONAHA.116.021230","article-title":"Ketones step to the plate: A game changer for metabolic remodeling in heart failure?","volume":"133","author":"Kolwicz","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.111016_b0485","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","article-title":"Physiological roles of ketone bodies as substrates and signals in mammalian tissues","volume":"60","author":"Robinson","year":"1980","journal-title":"Physiol Rev"},{"key":"10.1016\/j.diabres.2023.111016_b0490","doi-asserted-by":"crossref","first-page":"e0124844","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2023.111016_b0495","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.diabres.2023.111016_b0500","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.111016_b0505","doi-asserted-by":"crossref","first-page":"e006066","DOI":"10.1161\/JAHA.116.005066","article-title":"Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: A positron emission tomography study","volume":"6","author":"Gormsen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabres.2023.111016_b0510","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2007-1014756","article-title":"Regulation of substrate oxidation in isolated myocardial cells by beta-hydroxybutyrate","volume":"16","author":"Chen","year":"1984","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2023.111016_b0515","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2337\/db14-0694","article-title":"Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes","volume":"64","author":"Nolan","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0520","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db11-1275","article-title":"Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects","volume":"61","author":"Winhofer","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.111016_b0525","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2023.111016_b0530","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14656566.2023.2208746","article-title":"Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes","volume":"24","author":"Brodosi","year":"2023","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.diabres.2023.111016_b0535","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2023.111016_b0540","article-title":"Embedding assessment of liver fibrosis into routine diabetic review in primary care","volume":"3","author":"Mansour","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.diabres.2023.111016_b0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723007799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723007799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:18:55Z","timestamp":1787429935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723007799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":109,"alternative-id":["S0168822723007799"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.111016","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.111016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111016"}}